Skip to main content
Log in
Home
All Courses
904. Outcomes Research – Non-Malignant Conditions: Poster I
904. Outcomes Research – Non-Malignant Conditions: Poster I
Summary
Course
Credit Activity Report
PARS log
More
Course info
Conferences and Meetings
904. Outcomes Research – Non-Malignant Conditions: Poster I
904. Outcomes Research – Non-Malignant Conditions: Poster I
Category:
Conferences and Meetings
Short name:
updated-904. Outcomes Research – Non-Malignant Conditions: Poster I- 2023
Course start date:
01/12/2026
Course end date:
01/12/2027
Enroll me
Sections
General
0 activities
904. Outcomes Research – Non-Malignant Conditions: Poster I
0 activities
Clinical Factors Associated with Catheter-Related VTE in Patients Undergoing Hematopoietic Cell Transplantation
1 activities
Clinical Factors Associated with Catheter-Related VTE in Patients Undergoing Hematopoietic Cell Transplantation
Experience with Accelerometer Physical Activity Tracking in Adults and Adolescents with Hemophilia A: Tool Validation Using Results from the XTEND-1 E
1 activities
Experience with Accelerometer Physical Activity Tracking in Adults and Adolescents with Hemophilia A: Tool Validation Using Results from the XTEND-1 E
Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism
1 activities
Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism
Patients with Non-Transfusion-Dependent Thalassemia May Evolve to Transfusion-Dependent Thalassemia in Adulthood
1 activities
Patients with Non-Transfusion-Dependent Thalassemia May Evolve to Transfusion-Dependent Thalassemia in Adulthood
Oral Anticoagulant (OAC) Use Among Medicare Patients Newly Diagnosed with Venous Thromboembolism (VTE): Factors Associated with Treatment Status
1 activities
Oral Anticoagulant (OAC) Use Among Medicare Patients Newly Diagnosed with Venous Thromboembolism (VTE): Factors Associated with Treatment Status
Mitapivat Treatment Reduces Levels of Interference in Work/School Activity for Adult Patients with Pyruvate Kinase Deficiency
1 activities
Mitapivat Treatment Reduces Levels of Interference in Work/School Activity for Adult Patients with Pyruvate Kinase Deficiency
Preferences of Patients with Congenital Thrombotic Thrombocytopenic Purpura and Other Chronic Conditions for in-Home Prophylactic Infusions
1 activities
Preferences of Patients with Congenital Thrombotic Thrombocytopenic Purpura and Other Chronic Conditions for in-Home Prophylactic Infusions
Assessing Treatment Burden in Pediatric Hemophilia: Validation of the Observer-Reported Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)
1 activities
Assessing Treatment Burden in Pediatric Hemophilia: Validation of the Observer-Reported Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)
Immunotherapy-Related Hematological Adverse Events: Incidence and Outcomes
1 activities
Immunotherapy-Related Hematological Adverse Events: Incidence and Outcomes
Bleeding Risk from Anticoagulant Thromboprophylaxis in Patients with Multiple Myeloma
1 activities
Bleeding Risk from Anticoagulant Thromboprophylaxis in Patients with Multiple Myeloma
Immunoglobulins As a Predictor of Chronicity in Pediatric Immune Thrombocytopenia
1 activities
Immunoglobulins As a Predictor of Chronicity in Pediatric Immune Thrombocytopenia
Racial Discrimination and Pain in Adults with Sickle Cell Disease: Depression As a Mediator
1 activities
Racial Discrimination and Pain in Adults with Sickle Cell Disease: Depression As a Mediator
COVID-19 in Adults with Sickle Cell Disease
1 activities
COVID-19 in Adults with Sickle Cell Disease
Effects of Diaphragmatic Breathing in Sickle Cell Disease Patients: Preliminary Data
1 activities
Effects of Diaphragmatic Breathing in Sickle Cell Disease Patients: Preliminary Data
A Patient-Centric Approach to Sickle Cell Disease Clinical Trials: Integrating Patient Perspectives in the RISE UP Phase 2/3 Trial of Mitapivat for In
1 activities
A Patient-Centric Approach to Sickle Cell Disease Clinical Trials: Integrating Patient Perspectives in the RISE UP Phase 2/3 Trial of Mitapivat for In
Association of Health-Related Quality of Life and Work Productivity with Clinical Characteristics in Adults with Sickle Cell Disease
1 activities
Association of Health-Related Quality of Life and Work Productivity with Clinical Characteristics in Adults with Sickle Cell Disease
Executive Difficulties and Depressive Symptoms Predict Future Acute Pain Emergency Visits and Hospitalizations in Children with Sickle Cell Disease
1 activities
Executive Difficulties and Depressive Symptoms Predict Future Acute Pain Emergency Visits and Hospitalizations in Children with Sickle Cell Disease
Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia
1 activities
Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia
Real-World Unmet Needs in Patients with Hemophilia A without Inhibitors in the US: Results from the PicnicHealth Database
1 activities
Real-World Unmet Needs in Patients with Hemophilia A without Inhibitors in the US: Results from the PicnicHealth Database
Adults with Transfusion-Dependent Thalassemia Have Variable Clinical Profiles Depending on Where They Receive Care: Thalassemia Treatment Center Vs Co
1 activities
Adults with Transfusion-Dependent Thalassemia Have Variable Clinical Profiles Depending on Where They Receive Care: Thalassemia Treatment Center Vs Co
Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease
1 activities
Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease
Vimeo
21
Enroll me
Loading...
Help
Loading...
Accessibility
Text size
A-
A
A+
Color Adjustments
Monochrome
Low Saturation
High Saturation
High Contrast
Invert Colors
Change Hue
Reset Color Adjustments